Loading insider details...
Beta
Latest Form 4 (Aug 10, 2026): Exercise/Conversion of 6,786 CHE shares, $3.02M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 10, 2026 | CHEMED CORP (CHE) | Exercise/Conversion | 6,786 | $3.02M |
| Feb 17, 2026 | CHEMED CORP (CHE) | Exercise/Conversion | 351 | $164.8K |
| Oct 22, 2025 | CHEMED CORP (CHE) | Grant/Award | 15,017 | $6.66M |
| Feb 18, 2025 | CHEMED CORP (CHE) | Exercise/Conversion | 556 | $307.7K |
| Dec 30, 2024 | CHEMED CORP (CHE) | Purchase | 145 | $75.3K |
| Oct 23, 2024 | CHEMED CORP (CHE) | Grant/Award | 10,323 | $6.17M |
| Mar 22, 2024 | CHEMED CORP (CHE) | Exercise/Conversion | 5,825 | $2.41M |
| Feb 20, 2024 | CHEMED CORP (CHE) | Exercise/Conversion | 147 | $86.2K |
| Oct 26, 2023 | CHEMED CORP (CHE) | Grant/Award | 9,664 | $4.92M |
| Feb 22, 2023 | CHEMED CORP (CHE) | Exercise/Conversion | 374 | $192.7K |